Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 2
1(25.0%)
Phase 1
1(25.0%)
4Total
N/A(2)
Phase 2(1)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT01938352Phase 2Completed

Evaluation of the Protective Efficacy and Safety of CR8020 in an Influenza Challenge

Role: collaborator

NCT00947687Phase 1Completed

Safety and Efficacy Study of Inhaled PUR003 on a Controlled Influenza Virus Challenge in Healthy Adult Subjects

Role: collaborator

NCT01710111Not ApplicableCompleted

Evaluating Modes of Influenza Transmission

Role: collaborator

NCT01150149Not ApplicableWithdrawn

Evaluating Modes of Influenza Transmission Between Humans

Role: collaborator

All 4 trials loaded